Turn Therapeutics Inc. (NASDAQ:TTRX) People
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Andrew Gengos Other companies: Immuneering Corporation (Chief Financial Officer and Treasurer · Since at least Jul 16, 2026); Terns Pharmaceuticals, Inc. (Chief Financial Officer · Since at least Feb 24, 2025); LeonaBio, Inc. (CFO and Chief Business Officer · May 18, 2023 – Sep 3, 2024 · Past); Cyteir Therapeutics Inc (Chief Business Officer · Jun 17, 2021 – Feb 22, 2022 · Past); Synlogic Inc (Chief Operating Officer · Oct 9, 2017 – Mar 14, 2018 · Past) | Director · Since at least Oct 7, 2025 |
| Arthur Golden Other companies: Emerson Electric Company (Director · Feb 7, 2006 – Nov 8, 2023 · Past) | Director · Since at least Oct 7, 2025 |
| Martin Dewhurst Other companies: NovaBridge Biosciences (Independent Director · Since at least Sep 8, 2026) | Director · Since at least Jan 7, 2026 |
| Andrew Scott | Vice President of Corporate Communications · Nov 4, 2025 – Nov 5, 2026 · Past |
| Bradley Burnam | Chief Executive Officer · Since at least Oct 7, 2025 |
| Kent Kester | Director · Since at least Oct 7, 2025 |
| Muhammad Zubair | Controller · Since at least Nov 4, 2026 |
| Neilesh Shailesh Ghodadra | Chief Medical Officer, Director · Since at least Oct 7, 2025 |
| Neil Ghodadra | Chief Medical Officer, Board Director · Since at least Nov 4, 2026 |
| Robert R. Redfield | Chief Scientific Officer · Since at least Sep 9, 2026 |
| Sasha Damouni | Investor Relations / Media Contact · Since at least Sep 10, 2026 |
| Sasha Damouni Ellis | Corporate Communications & IR Lead · Since at least Jul 6, 2026 |
| Stephen M. Hahn | Executive Clinical and Regulatory Lead · Since at least Aug 12, 2026 |
| Zuraiz Chaudhary | Chief Accounting Officer, VP Finance · Since at least Oct 7, 2025 |